RESUMO
Fibrosing chronic graft-versus-host disease (cGVHD) is a debilitating complication of allogeneic stem cell transplantation (alloSCT). A driver of fibrosis is the kynurenine (Kyn) pathway, and Kyn metabolism patterns and cytokines may influence cGVHD severity and manifestation (fibrosing versus gastrointestinal [GI] cGVHD). Using a liquid chromatography-tandem mass spectrometry approach on sera obtained from 425 patients with allografts, we identified high CXCL9, high indoleamine-2,3-dioxygenase (IDO) activity, and an activated Kyn pathway as common characteristics in all cGVHD subtypes. Specific Kyn metabolism patterns could be identified for non-severe cGVHD, severe GI cGVHD, and fibrosing cGVHD, respectively. Specifically, fibrosing cGVHD was associated with a distinct pathway shift toward anthranilic and kynurenic acid, correlating with reduced activity of the vitamin-B2-dependent kynurenine monooxygenase, low vitamin B6, and increased interleukin-18. The Kyn metabolite signature is a candidate biomarker for severe fibrosing cGVHD and provides a rationale for translational trials on prophylactic vitamin B2/B6 supplementation for cGVHD prevention.
Assuntos
Doença Enxerto-Hospedeiro/sangue , Ácido Cinurênico/sangue , Cinurenina/sangue , Riboflavina/sangue , Transplante de Células-Tronco , Vitamina B 6/sangue , Adolescente , Adulto , Idoso , Quimiocina CXCL9/sangue , Quimiocina CXCL9/genética , Feminino , Fibrose , Regulação da Expressão Gênica , Doença Enxerto-Hospedeiro/genética , Doença Enxerto-Hospedeiro/patologia , Humanos , Indolamina-Pirrol 2,3,-Dioxigenase/sangue , Indolamina-Pirrol 2,3,-Dioxigenase/genética , Interleucina-18/sangue , Interleucina-18/genética , Quinurenina 3-Mono-Oxigenase/sangue , Quinurenina 3-Mono-Oxigenase/genética , Leucemia/genética , Leucemia/metabolismo , Leucemia/patologia , Leucemia/terapia , Linfoma/genética , Linfoma/metabolismo , Linfoma/patologia , Linfoma/terapia , Masculino , Redes e Vias Metabólicas/genética , Pessoa de Meia-Idade , Estudos Retrospectivos , Índice de Gravidade de Doença , Transdução de Sinais , Transplante Homólogo , Triptofano/sangue , ortoaminobenzoatos/sangueRESUMO
BACKGROUND: Maternal supplementation during lactation could increase milk B-vitamin concentrations, but little is known about the kinetics of milk vitamin responses. OBJECTIVES: We compared acute effects of maternal lipid-based nutrient supplement (LNS) consumption (n = 22 nutrients, 175%-212% of the RDA intake for the nutrients examined), as a single dose or at spaced intervals during 8 h, on milk concentrations and infant intake from milk of B-vitamins. METHODS: This randomized crossover trial in Quetzaltenango, Guatemala included 26 mother-infant dyads 4-6 mo postpartum who were randomly assigned to receive 3 treatments in a random order: bolus 30-g dose of LNS (Bolus); 3 × 10-g doses of LNS (Divided); and no LNS (Control), with control meals. Mothers attended three 8-h visits during which infant milk consumption was measured and milk samples were collected at every feed. Infant intake was assessed as $\mathop \sum \nolimits_{i\ = \ 1}^n ( {{\rm{milk\ volum}}{{\rm{e}}_{{\rm{feed\ }}n}} \times \ {\rm{nutrient\ concentratio}}{{\rm{n}}_{{\rm{feed}}\ n}}} )$ over 8 h. RESULTS: Maternal supplementation with the Bolus or Divided dose increased least-squares mean (95% CI) milk and infant intakes of riboflavin [milk: Bolus: 154.4 (138.2, 172.5) µg · min-1 · mL-1; Control: 84.5 (75.8, 94.3) µg · min-1 · mL-1; infant: Bolus: 64.5 (56.1, 74.3) µg; Control: 34.5 (30.0, 39.6) µg], thiamin [milk: Bolus: 10.9 (10.1, 11.7) µg · min-1 · mL-1; Control: 7.7 (7.2, 8.3) µg · min-1 · mL-1; infant: Bolus: 5.1 (4.4, 6.0) µg; Control: 3.4 (2.9, 4.0) µg], and pyridoxal [milk: Bolus: 90.5 (82.8, 98.9) µg · min-1 · mL-1; Control: 60.8 (55.8, 66.3) µg · min-1 · mL-1; infant: Bolus: 39.4 (33.5, 46.4) µg; Control: 25.0 (21.4, 29.2) µg] (all P < 0.001). Only the Bolus dose increased cobalamin in milk [Bolus: 0.054 (0.047, 0.061) µg · min-1 · mL-1; Control: 0.041 (0.035, 0.048) µg · min-1 · mL-1, P = 0.039] and infant cobalamin intake [Bolus: 0.023 (0.020, 0.027) µg; Control: 0.015 (0.013, 0.018) µg, P = 0.001] compared with Control. Niacin was unaffected. CONCLUSIONS: Maternal supplementation with LNS as a Bolus or Divided dose was similarly effective at increasing milk riboflavin, thiamin, and pyridoxal and infant intakes, whereas only the Bolus dose increased cobalamin. Niacin was unaffected in 8 h. This trial was registered at clinicaltrials.gov as NCT02464111.
Assuntos
Aleitamento Materno , Lactação , Micronutrientes/administração & dosagem , Micronutrientes/sangue , Vitaminas/administração & dosagem , Vitaminas/sangue , Adulto , Área Sob a Curva , Estudos Cross-Over , Suplementos Nutricionais , Feminino , Guatemala , Humanos , Lactente , Micronutrientes/química , Leite Humano/química , Niacina/administração & dosagem , Niacina/sangue , Niacina/farmacocinética , Piridoxal/administração & dosagem , Piridoxal/sangue , Piridoxal/farmacocinética , Riboflavina/administração & dosagem , Riboflavina/sangue , Riboflavina/farmacocinética , Tiamina/administração & dosagem , Tiamina/sangue , Tiamina/farmacocinética , Vitamina B 12/administração & dosagem , Vitamina B 12/sangue , Vitamina B 12/farmacocinética , Vitaminas/farmacocinética , Adulto JovemRESUMO
Vitamin B2 (riboflavin) is an essential constituent of the coenzymes flavin mononucleotide and flavin adenine dinucleotide and is critical for human metabolism and energy production. Liquid chromatography separation, then tandem mass spectrometry detection (LC-MS/MS) is a highly specific technique that enables quick analysis. An isotope dilution method for determination of riboflavin in human plasma using LC-MS/MS has been developed and validated in this study. In this method, 100⯵L of plasma were added of 75⯵L of an internal standard and treated with 125⯵L of 0.1â¯M zinc sulfate. The analysis was performed using an Agilent 6460C tandem mass spectrometer system operated in the positive-ion mode. Chromatography separation performance was obtained with an Agilent 1290 UHPLC equipped with a Poroshell 120 SB-Aq column (100â¯mmâ¯×â¯2.1â¯mmâ¯×â¯2.7⯵m) at a flow rate of 350⯵L·min-1. Riboflavin was measured within an instrument run time of 2.5â¯min. Riboflavin content was found to follow a linear trend in the 0.5 to 50.0â¯ng·mL-1 range and dilution was validated for samples that exceed the last point of the calibration curve until two times. The intra-day relative standard deviation (RSD) was less than 10% and inter-day RSD was less than 11%. The average of recovery was 90.5-99.5%. A sensitive and selective method has been developed and validated successfully for quantitative analysis of riboflavin in human plasma with a simple sample extraction method and short execution time. The method is reliable and can be applied in clinical diagnosis of deficiency and supplementation monitored of this vitamin.
Assuntos
Cromatografia Líquida/métodos , Riboflavina/sangue , Espectrometria de Massas em Tandem/métodos , Humanos , Limite de Detecção , Modelos Lineares , Reprodutibilidade dos TestesRESUMO
Previous studies have found associations between one-carbon metabolism nutrients and risk of several cancers, but little is known regarding upper gastrointestinal tract (UGI) cancer. We analyzed prediagnostic serum concentrations of several one-carbon metabolism nutrients (vitamin B12, folate, vitamin B6, riboflavin and homocysteine) in a nested case-control study within the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study of male smokers, which was undertaken in Finland between 1985 and 1988. We conducted a nested case-control study including 127 noncardia gastric adenocarcinoma (NCGA), 41 esophagogastric junctional adenocarcinoma and 60 esophageal squamous cell carcinoma incident cases identified within ATBC. Controls were matched to cases on age, date of serum collection and follow-up time. One-carbon nutrient concentrations were measured in fasting serum samples collected at baseline (up to 17 years prior to cancer diagnosis). Odds ratios and 95% confidence intervals (CI) were calculated using conditional logistic regression. Lower prediagnostic vitamin B12 concentrations at baseline were associated with a 5.8-fold increased risk of NCGA (95% CI = 2.7-12.6 for lowest compared to highest quartile, p-trend <0.001). This association remained in participants who developed cancer more than 10 years after blood collection, and after restricting the analysis to participants with clinically normal serum vitamin B12 (>300 pmol/L). In contrast, pepsinogen I, a known serologic marker of gastric atrophy, was not associated with NCGA in this population. As vitamin B12 absorption requires intact gastric mucosa to produce acid and intrinsic factor, our findings suggest vitamin B12 as a possible serologic marker for the atrophic gastritis that precedes NCGA, one more strongly associated with subsequent NCGA than pepsinogen.
Assuntos
Carcinoma de Células Escamosas/sangue , Neoplasias Esofágicas/sangue , Neoplasias Gástricas/sangue , Deficiência de Vitamina B 12/sangue , Vitamina B 12/sangue , Idoso , Carcinoma de Células Escamosas/epidemiologia , Carcinoma de Células Escamosas/patologia , Estudos de Casos e Controles , Suplementos Nutricionais , Neoplasias Esofágicas/epidemiologia , Neoplasias Esofágicas/patologia , Carcinoma de Células Escamosas do Esôfago , Finlândia/epidemiologia , Ácido Fólico/sangue , Homocisteína/sangue , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Riboflavina/sangue , Neoplasias Gástricas/epidemiologia , Neoplasias Gástricas/patologia , Deficiência de Vitamina B 12/patologia , alfa-Tocoferol/administração & dosagem , beta Caroteno/administração & dosagemRESUMO
Experimental studies suggest a protective effect of B-vitamins on breast cancer risk, potentially modulated by alcohol intake. However, epidemiological studies are limited, especially regarding non-folate B-vitamins. Furthermore, few studies included quantitative assessment of supplemental intake. This prospective study aimed to investigate the associations between intakes of B-vitamins (dietary, supplemental, total) and breast cancer risk. 27,853 women aged ≥45 years from the NutriNet-Santé cohort (2009-2016) were included, with a median follow-up time of 4.2 years. Dietary data were collected using repeated 24 h records. A specific questionnaire assessed dietary supplement use over a 12-month period. A composition database of 8000 supplements was developed. Associations were characterized by multivariable Cox models, and 462 incident breast cancers were diagnosed. Dietary (HRQ4vs.Q1 = 0.74 (0.55, 0.99), P-trend = 0.05), supplemental (HRQ4vs.Q1 = 0.61 (0.38, 0.98), P-trend = 0.05), and total (HRQ4vs.Q1 = 0.67 (0.50, 0.91), P-trend = 0.01) pyridoxine intakes were inversely associated with breast cancer risk. Total thiamin intake was borderline inversely associated with breast cancer risk (HRper 1-unit increment = 0.78 (0.61, 1.00), P = 0.05). Statistically significant interactions between alcohol consumption and B-vitamin (thiamin, riboflavin, niacin, pantothenic acid, pyridoxine, folate, and cobalamin) supplemental intake were observed, the latter being inversely associated with breast cancer risk in non-to-low alcohol drinkers but not in higher drinkers. This large prospective study, including quantitative assessment of supplemental intake, suggests a potential protective effect of pyridoxine and thiamin on breast cancer risk in middle-aged women.
Assuntos
Neoplasias da Mama/prevenção & controle , Dieta , Suplementos Nutricionais , Complexo Vitamínico B/administração & dosagem , Complexo Vitamínico B/sangue , Idoso , Consumo de Bebidas Alcoólicas/efeitos adversos , Exercício Físico , Feminino , Seguimentos , Comportamentos Relacionados com a Saúde , Humanos , Pessoa de Meia-Idade , Avaliação Nutricional , Modelos de Riscos Proporcionais , Estudos Prospectivos , Piridoxina/administração & dosagem , Piridoxina/sangue , Riboflavina/administração & dosagem , Riboflavina/sangue , Fatores de Risco , Fatores Socioeconômicos , Inquéritos e Questionários , Tiamina/administração & dosagem , Tiamina/sangueRESUMO
Many children suffer from nutritional deficiencies that may negatively affect their academic performance. This cluster-randomized controlled trial aimed to test the effects of micronutrient-fortified milk in Chinese students. Participants received either micronutrient-fortified (n = 177) or unfortified (n = 183) milk for six months. Academic performance, motivation, and learning strategies were estimated by end-of-term tests and the Motivated Strategies for Learning Questionnaire. Blood samples were analyzed for micronutrients. In total, 296 students (82.2%) completed this study. Compared with the control group, students in the intervention group reported higher scores in several academic subjects (p < 0.05), including languages, mathematics, ethics, and physical performance at the end of follow-up. Students in the intervention group showed greater self-efficacy and use of cognitive strategies in learning, and reported less test anxiety (p < 0.001). Moreover, vitamin B2 deficiency (odds ratio (OR) = 0.18, 95% confidence interval (CI): 0.11~0.30) and iron deficiency (OR = 0.34, 95% CI: 0.14~0.81) were less likely in the students of the intervention group, whereas vitamin D, vitamin B12, and selenium deficiencies were not significantly different. "Cognitive strategy" had a partial mediating effect on the test scores of English (95% CI: 1.26~3.79) and Chinese (95% CI: 0.53~2.21). Our findings suggest that micronutrient-fortified milk may improve students' academic performance, motivation, and learning strategies.
Assuntos
Escolaridade , Alimentos Fortificados , Desnutrição/epidemiologia , Micronutrientes/deficiência , Leite/química , Adolescente , Anemia Ferropriva/sangue , Anemia Ferropriva/epidemiologia , Animais , Povo Asiático , Índice de Massa Corporal , Criança , China/epidemiologia , Análise por Conglomerados , Dieta , Feminino , Seguimentos , Humanos , Ferro/administração & dosagem , Ferro/sangue , Modelos Logísticos , Masculino , Desnutrição/sangue , Desnutrição/dietoterapia , Micronutrientes/administração & dosagem , Micronutrientes/sangue , Estado Nutricional , Prevalência , Riboflavina/administração & dosagem , Riboflavina/sangue , Deficiência de Riboflavina/sangue , Deficiência de Riboflavina/epidemiologia , Selênio/administração & dosagem , Selênio/sangue , Selênio/deficiência , Estudantes , Inquéritos e Questionários , Vitamina A/administração & dosagem , Vitamina A/sangue , Vitamina B 12/administração & dosagem , Vitamina B 12/sangue , Vitamina D/administração & dosagem , Vitamina D/sangueRESUMO
Riboflavin is an essential micronutrient for normal cellular activity, and deficiency may result in disease, such as cancer. We performed a case-control study to explore the association of riboflavin levels with risk and prognosis of esophageal squamous cell carcinoma (ESCC). Plasma riboflavin levels, as measured by enzyme-linked immunosorbent assay (ELISA), in ESCC patients were significantly lower than in those of healthy controls (7.04 ± 6.34 ng/ml vs. 9.32 ± 12.40 ng/ml; P < 0.05). Moreover, there was an inverse relationship between riboflavin level and risk of ESCC (odds ratio (OR) = 0.97, 95% confidence interval (CI) = 0.95-0.99, P = 0.02). The 5-year relapse-free and overall survival rates were significantly lower when riboflavin levels were ≤0.8 ng/ml than >0.8 ng/ml (relapse-free survival rate: 29.4% vs. 54.8%; overall survival rate: 28.6% vs. 55.6%). Plasma riboflavin level was an independent protective factor for both relapse-free (hazard ratio (HR) = 0.325, 95% CI = 0.161-0.657, P = 0.002) and overall survival of ESCC patients (HR = 0.382, 95% CI = 0.190-0.768, P = 0.007). In conclusion, plasma riboflavin levels are significantly related to risk and prognosis of ESCC patients, suggesting that moderate supplementation of riboflavin will decrease risk and prevent recurrence of ESCC and also improve prognosis of ESCC patients.
Assuntos
Carcinoma de Células Escamosas/mortalidade , Carcinoma de Células Escamosas/patologia , Neoplasias Esofágicas/mortalidade , Neoplasias Esofágicas/patologia , Riboflavina/sangue , Adulto , Idoso , Idoso de 80 Anos ou mais , Biomarcadores Tumorais/sangue , Carcinoma de Células Escamosas/sangue , Estudos de Casos e Controles , Neoplasias Esofágicas/sangue , Carcinoma de Células Escamosas do Esôfago , Feminino , Humanos , Estimativa de Kaplan-Meier , Masculino , Proteínas de Membrana Transportadoras/genética , Pessoa de Meia-Idade , Polimorfismo de Nucleotídeo Único , PrognósticoRESUMO
OBJECTIVE: To assess the situations of dietary vitamins intakes among aged 60 years old adults in different areas of Zhejiang Province, and analyze the food sources of vitamins. METHODS: Data were obtained from the 2010-2012 Chinese National Nutrition and Health Survey in Zhejiang Province. Dietary intakes among elderly people of vitamin A, vitamin B_1, vitamin B_2, vitamin C, vitamin E and their sources were acquired by 24-hour dietary recalls for 3 days in different areas. RESULTS: The elderly people' intakes of VA(296. 85(174. 32, 500. 28) µg RAE/d), VB_1(0. 68(0. 47, 0. 96) mg/d), VB2(0. 65(0. 47, 0. 90) mg /d) and VC(54. 54(33. 65, 83. 82) mg/d) were generally low. Intakes of vitamin B_1, vitamin C and vitamin E were significantly different in different areas( χ~2=41. 201, 39. 262 and 19. 474, P<0. 001). The food sources of vitamins were slightly variant. CONCLUSION: The insufficient status of vitamins intakes among elderly people in Zhejiang was serious, and there were differences among elderly people from different areas in intakes and food sources of vitamins.
Assuntos
Dieta , Suplementos Nutricionais , Vitaminas/administração & dosagem , Adulto , Idoso , Idoso de 80 Anos ou mais , Ácido Ascórbico/administração & dosagem , Ácido Ascórbico/sangue , Feminino , Inquéritos Epidemiológicos , Humanos , Estado Nutricional , Riboflavina/administração & dosagem , Riboflavina/sangue , Tiamina/administração & dosagem , Tiamina/sangue , Vitamina A/administração & dosagem , Vitamina A/sangue , Vitamina D/administração & dosagem , Vitamina D/sangue , Vitamina E/administração & dosagem , Vitamina E/sangue , Vitaminas/sangue , Vitaminas/metabolismoAssuntos
Riboflavina/efeitos adversos , Riboflavina/sangue , Riboflavina/química , Riboflavina/farmacologia , Dieta , Suplementos Nutricionais , Relação Dose-Resposta a Droga , Humanos , Inquéritos Nutricionais , Recomendações Nutricionais , Deficiência de Riboflavina/sangue , Deficiência de Riboflavina/diagnósticoRESUMO
Homeostasis of riboflavin should be maintained by transporters. Previous in vitro studies have elucidated basic information about riboflavin transporter RFVT3 encoded by SLC52A3 gene. However, the contribution of RFVT3 to the maintenance of riboflavin homeostasis and the significance in vivo remain unclear. Here, we investigated the physiological role of RFVT3 using Slc52a3 knockout (Slc52a3-/-) mice. Most Slc52a3-/- mice died with hyperlipidemia and hypoglycemia within 48 hr after birth. The plasma and tissue riboflavin concentrations in Slc52a3-/- mice at postnatal day 0 were dramatically lower than those in wild-type (WT) littermates. Slc52a3-/- fetuses showed a lower capacity of placental riboflavin transport compared with WT fetuses. Riboflavin supplement during pregnancy and after birth reduced neonatal death and metabolic disorders. To our knowledge, this is the first report to indicate that Rfvt3 contributes to placental riboflavin transport, and that disruption of Slc52a3 gene caused neonatal mortality with hyperlipidemia and hypoglycemia owing to riboflavin deficiency.
Assuntos
Proteínas de Membrana Transportadoras/genética , Deficiência de Riboflavina/genética , Riboflavina/sangue , Animais , Animais Recém-Nascidos/genética , Feminino , Humanos , Hiperlipidemias/genética , Hiperlipidemias/mortalidade , Hiperlipidemias/patologia , Hipoglicemia/genética , Hipoglicemia/mortalidade , Hipoglicemia/patologia , Camundongos , Camundongos Knockout , Placenta/metabolismo , Placenta/patologia , Gravidez , Riboflavina/genética , Deficiência de Riboflavina/mortalidade , Deficiência de Riboflavina/patologiaRESUMO
Clinical deficiency of the B-vitamin riboflavin (vitamin B2) is largely confined to developing countries; however accumulating evidence indicates that suboptimal riboflavin status is a widespread problem across the developed world. Few international data are available on riboflavin status as measured by the functional biomarker, erythrocyte glutathione reductase activation coefficient, considered to be the gold standard index. One important role of riboflavin in the form of flavin dinucleotide is as a co-factor for the folate-metabolising enzyme methylenetetrahydrofolate reductase (MTHFR). Homozygosity for the common C677T polymorphism in MTHFR, affecting over 10 % of the UK and Irish populations and up to 32 % of other populations worldwide, has been associated with an increased risk of CVD, and more recently with hypertension. This review will explore available studies reporting riboflavin status worldwide, the interaction of riboflavin with the MTHFR C677T polymorphism and the potential role of riboflavin in personalised nutrition. Evidence is accumulating for a novel role of riboflavin as an important modulator of blood pressure (BP) specifically in individuals with the MTHFR 677TT genotype, with results from a number of recent randomised controlled trials demonstrating that riboflavin supplementation can significantly reduce systolic BP by 5-13 mmHg in these genetically at risk adults. Studies are however required to investigate the BP-lowering effect of riboflavin in different populations and in response to doses higher than 1·6 mg/d. Furthermore, work focusing on the translation of this research to health professionals and patients is also required.
Assuntos
Pressão Sanguínea/efeitos dos fármacos , Metilenotetra-Hidrofolato Redutase (NADPH2)/genética , Estado Nutricional , Riboflavina/sangue , Animais , Biomarcadores/sangue , Suplementos Nutricionais , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Ácido Fólico/administração & dosagem , Ácido Fólico/sangue , Genótipo , Homozigoto , Humanos , Irlanda , Necessidades Nutricionais , Polimorfismo de Nucleotídeo Único , Ensaios Clínicos Controlados Aleatórios como Assunto , Deficiência de Riboflavina/sangue , Deficiência de Riboflavina/tratamento farmacológico , Fatores de Risco , Reino UnidoRESUMO
Urinary riboflavin excretion and erythrocyte glutathione reductase activation coefficient are frequently applied in determining riboflavin requirement. Previously, we found that plasma riboflavin is a sensitive marker in the assessment of riboflavin status in rat models. Here, we hypothesize that plasma riboflavin is a useful maker in studying riboflavin requirement. This study examines the changes of fasting plasma riboflavin and urinary riboflavin excretion in response to different riboflavin intake levels in Chinese male adults. The estimated average requirement (EAR) of riboflavin was extrapolated. Seventy-eight participants were randomly divided into the control and 5 riboflavin-supplemented groups. A 6-week riboflavin supplementation was performed at the doses of 0, 0.2, 0.4, 0.6, 0.8, or 1.0 mg daily. The energy expenditure was 15.4 ± 1.9 MJ/d, as estimated by the 24-hour physical activity recording method. Dietary riboflavin intake was 1.0 ± 0.2 mg/d, based on chemical analysis. The fasting plasma riboflavin was increased significantly in a dose-dependent manner when the supplemented riboflavin exceeded 0.4 mg/d and the EAR of riboflavin was suggested to be between 1.3 and 1.5 mg/d. In addition, we found a significant increase in fasting urinary riboflavin excretion when the supplemented riboflavin exceeded 0.6 mg/d. The critical point was calculated as 1.4 mg/d, based on the intersecting point of the 2 regression lines at lower and higher riboflavin intakes. These findings demonstrate that plasma riboflavin is a sensitive marker for riboflavin status, and the EAR of riboflavin for Chinese male adults is 1.4 mg.
Assuntos
Povo Asiático , Necessidades Nutricionais , Riboflavina/sangue , Adolescente , Adulto , Índice de Massa Corporal , Peso Corporal , Dieta , Suplementos Nutricionais , Relação Dose-Resposta a Droga , Metabolismo Energético , Eritrócitos , Exercício Físico , Jejum , Humanos , Masculino , Avaliação Nutricional , Riboflavina/administração & dosagem , Riboflavina/urina , Adulto JovemRESUMO
Multiple micronutrient deficiencies exist in school going children in India and bridging the gap between nutrient intake and requirements is an effective way to combat the deficiencies. This study aimed to test the effect of a multi-micronutrient fortified malt and cocoa based milk beverage on the micronutrient status, cognition, physical performance and nutritional deficiencies of 7-10 years old south Indian children. A randomized, double blind placebo controlled study design was used with normal healthy children from low to middle income families, aged 7-10 years randomly assigned to receive either a multi-micronutrient fortified or an unfortified milk based control drink. The drinks were provided 6 days/week for 5 months. Assessments included anthropometry, blood biochemistry, physical performance and cognition at baseline and endline. The baseline characteristics of the study groups were similar. The changes in body weight and height were similar between the groups at the end of the study. Levels of vitamin B12, red cell folate and vitamin B2 significantly improved in the intervention group, while vitamin D, selenium and body iron showed no difference. The Hemoglobin (Hb) and serum ferritin levels of the control group decreased at endline, while those in the intervention group maintained their levels. The serum transferrin receptor levels increased in both the groups. The prevalence of iron deficiency and Vitamin B2 deficiency were significantly lower in the intervention group at endline. Overall improvement in cognitive and physical performance was seen in both the groups at endline, with no significant differences between the groups. The micronutrient fortified milk based drink was efficacious in improving the micronutrient status of Vitamin B2, Vitamin B12 and red cell folate and in preventing a decline in Hb level compared to an unfortified milk based drink. It also reduced anemia and the risk of deficiencies of iron, and B12, in apparently healthy children. ClinicalTrials.gov IdentifierNCT01415557. Clinical Trial RegistryIndia - REF/2012/12/004332.
Assuntos
Cognição , Alimentos Fortificados , Micronutrientes/administração & dosagem , Leite/química , Anemia Ferropriva/sangue , Anemia Ferropriva/prevenção & controle , Animais , Índice de Massa Corporal , Peso Corporal , Criança , Método Duplo-Cego , Feminino , Ferritinas/sangue , Ácido Fólico/administração & dosagem , Ácido Fólico/sangue , Hemoglobinas/metabolismo , Humanos , Índia , Ferro da Dieta/administração & dosagem , Ferro da Dieta/sangue , Masculino , Micronutrientes/sangue , Micronutrientes/deficiência , Estado Nutricional , Receptores da Transferrina/sangue , Riboflavina/administração & dosagem , Riboflavina/sangue , Deficiência de Riboflavina/sangue , Deficiência de Riboflavina/prevenção & controle , Selênio/administração & dosagem , Selênio/sangue , Vitamina B 12/administração & dosagem , Vitamina B 12/sangue , Deficiência de Vitamina B 12/sangue , Deficiência de Vitamina B 12/prevenção & controle , Vitamina D/administração & dosagem , Vitamina D/sangueRESUMO
BACKGROUND: Exclusive breastfeeding for 6 months is assumed to ensure adequate micronutrients for term infants. Our objective was to investigate the effects of prolonged breastfeeding on B vitamin status and neurodevelopment in 80 infants with subnormal birth weights (2000-3000 g) and examine if cobalamin supplementation may benefit motor function in infants who developed biochemical signs of impaired cobalamin function (total homocysteine (tHcy) > 6.5 µmol/L) at 6 months. METHODS: Levels of cobalamin, folate, riboflavin and pyridoxal 5´-phosphate, and the metabolic markers tHcy and methylmalonic acid (MMA), were determined at 6 weeks, 4 and 6 months (n = 80/68/66). Neurodevelopment was assessed with the Alberta Infants Motor Scale (AIMS) and the parental questionnaire Ages and Stages (ASQ) at 6 months. At 6 months, 32 of 36 infants with tHcy > 6.5 µmol/L were enrolled in a double blind randomized controlled trial to receive 400 µg hydroxycobalamin intramuscularly (n = 16) or sham injection (n = 16). Biochemical status and neurodevelopment were evaluated after one month. RESULTS: Except for folate, infants who were exclusively breastfed for >1 month had lower B vitamin levels at all assessments and higher tHcy and MMA levels at 4 and 6 months. At 6 months, these infants had lower AIMS scores (p = 0.03) and ASQ gross motor scores (p = 0.01). Compared to the placebo group, cobalamin treatment resulted in a decrease in plasma tHcy (p < 0.001) and MMA (p = 0.001) levels and a larger increase in AIMS (p = 0.02) and ASQ gross motor scores (p = 0.03). CONCLUSIONS: The findings suggest that prolonged exclusive breastfeeding may not provide sufficient B vitamins for small infants, and that this may have a negative effect on early gross motor development. In infants with mild cobalamin deficiency at 6 months, cobalamin treatment significantly improvement cobalamin status and motor function, suggesting that the observed impairment in motor function associated with long-term exclusive breastfeeding, may be due to cobalamin deficiency. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, number NCT01201005.
Assuntos
Aleitamento Materno , Desenvolvimento Infantil , Suplementos Nutricionais , Destreza Motora , Deficiência de Vitamina B 12/tratamento farmacológico , Vitamina B 12/uso terapêutico , Complexo Vitamínico B/uso terapêutico , Feminino , Ácido Fólico/sangue , Homocisteína/sangue , Humanos , Lactente , Recém-Nascido de Baixo Peso , Masculino , Ácido Metilmalônico/sangue , Fosfato de Piridoxal/sangue , Riboflavina/sangue , Fatores de Tempo , Vitamina B 12/sangue , Deficiência de Vitamina B 12/sangueRESUMO
To assess the ingestion of folate and nutrients involved in the 1-carbon cycle in non-treated patients with colorectal adenocarcinoma in a reference center for oncology in southeastern Brazil. In total, 195 new cases with colorectal adenocarcinoma completed a clinical evaluation questionnaire and a Food Frequency Questionnaire (FFQ). Blood samples from 161 patients were drawn for the assessment of serum folate. A moderate correlation was found between serum concentrations of folate, folate intake and the dietary folate equivalent (DFE) of synthetic supplements. Mulatto or black male patients with a primary educational level had a higher intake of dietary folate. Of patients obtaining folate from the diet alone or from dietary supplements, 11.00% and 0.10%, respectively, had intake below the recommended level. Of the patients using dietary supplements, 35% to 50% showed high levels of folic acid intake. There was a prevalence of inadequacy for vitamins B2, B6 and B12, ranging from 12.10% to 20.18%, while 13.76% to 22.55% of patients were likely to have adequate choline intake. The considerable percentage of patients with folate intake above the recommended levels deserves attention because of the harmful effects that this nutrient may have in the presence of established neoplastic lesions.
Assuntos
Ciclo do Carbono , Neoplasias Colorretais/tratamento farmacológico , Ácido Fólico/sangue , Idoso , Brasil , Colina/administração & dosagem , Colina/sangue , Carboidratos da Dieta/administração & dosagem , Proteínas Alimentares/administração & dosagem , Suplementos Nutricionais , Ingestão de Energia , Feminino , Ácido Fólico/administração & dosagem , Humanos , Masculino , Pessoa de Meia-Idade , Riboflavina/sangue , Inquéritos e Questionários , Vitamina B 12/sangue , Vitamina B 6/sangueRESUMO
BACKGROUND: Lipid-based nutrient supplements (LNS) have been effective in the treatment of acute malnutrition among children. We evaluated the use of LNS supplementation for improving the micronutrient status of young children. METHODS: A 12-month randomised controlled trial was conducted among children aged 6-18 months living in Intibucá, Honduras. Communities (n = 18) were randomised into clusters matched by poverty indicators (9 intervention, n = 160 and 9 controls, n = 140). Intervention participants received LNS. All children received food vouchers and nutrition education. Primary outcomes included measures of micronutrient status: at baseline, 6 and 12 months' blood were collected for assessment of folate, iron, zinc, riboflavin, and vitamin B12 status; haemoglobin was measured every 3 months; and dietary and anthropometry collected monthly. Longitudinal analyses were based on intent to treat and LNS adherence. Generalised estimating equations were used in the estimation of generalised linear regression models specified for the data. RESULTS: At 6-month follow-up, children in the intervention group had a lower proportion classified as deficient for B12 (43.6%) compared with the control (67.7%; P = 0.03). The intervention group had a higher mean concentration for folate at 6 months (P = 0.06), and improvements continued through 12 months for folate (P = 0.002) and vitamin A deficiency (P = 0.03). This pattern of results, with improved significance, remained in subanalysis based on LNS adherence. CONCLUSION: These data demonstrate that LNS improved select micronutrient status in young non-malnourished Honduran children.
Assuntos
Gorduras na Dieta/administração & dosagem , Suplementos Nutricionais , Fenômenos Fisiológicos da Nutrição do Lactente , Desnutrição/prevenção & controle , Micronutrientes/administração & dosagem , Populações Vulneráveis , Desenvolvimento Infantil , Análise por Conglomerados , Feminino , Ácido Fólico/sangue , Seguimentos , Honduras/epidemiologia , Humanos , Lactente , Ferro/sangue , Lipídeos/sangue , Masculino , Micronutrientes/deficiência , Estado Nutricional , Riboflavina/sangue , População Rural , Resultado do Tratamento , Vitamina B 12/sangue , Zinco/sangueRESUMO
BACKGROUND: Animal models show that periconceptional supplementation with folic acid, vitamin B-12, choline, and betaine can induce differences in offspring phenotype mediated by epigenetic changes in DNA. In humans, altered DNA methylation patterns have been observed in offspring whose mothers were exposed to famine or who conceived in the Gambian rainy season. OBJECTIVE: The objective was to understand the seasonality of DNA methylation patterns in rural Gambian women. We studied natural variations in dietary intake of nutrients involved in methyl-donor pathways and their effect on the respective metabolic biomarkers. DESIGN: In 30 women of reproductive age (18-45 y), we monitored diets monthly for 1 y by using 48-h weighed records to measure intakes of choline, betaine, folate, methionine, riboflavin, and vitamins B-6 and B-12. Blood biomarkers of these nutrients, S-adenosylhomocysteine (SAH), S-adenosylmethionine (SAM), homocysteine, cysteine, and dimethylglycine were also assessed monthly. RESULTS: Dietary intakes of riboflavin, folate, choline, and betaine varied significantly by season; the most dramatic variation was seen for betaine. All metabolic biomarkers showed significant seasonality, and vitamin B-6 and folate had the highest fluctuations. Correlations between dietary intakes and blood biomarkers were found for riboflavin, vitamin B-6, active vitamin B-12 (holotranscobalamin), and betaine. We observed a seasonal switch between the betaine and folate pathways and a probable limiting role of riboflavin in these processes and a higher SAM/SAH ratio during the rainy season. CONCLUSIONS: Naturally occurring seasonal variations in food-consumption patterns have a profound effect on methyl-donor biomarker status. The direction of these changes was consistent with previously reported differences in methylation of metastable epialleles. This trial was registered at www.clinicaltrials.gov as NCT01811641.
Assuntos
Biomarcadores/sangue , Metilação de DNA , Dieta , Comportamento Alimentar , População Rural , Adolescente , Adulto , Betaína/administração & dosagem , Betaína/sangue , Colina/administração & dosagem , Colina/sangue , Cisteína/sangue , Registros de Dieta , Carboidratos da Dieta/administração & dosagem , Gorduras na Dieta/administração & dosagem , Proteínas Alimentares/administração & dosagem , Feminino , Ácido Fólico/administração & dosagem , Ácido Fólico/sangue , Gâmbia , Homocisteína/sangue , Humanos , Modelos Lineares , Metionina/administração & dosagem , Metionina/sangue , Pessoa de Meia-Idade , Avaliação Nutricional , Estudos Prospectivos , Riboflavina/administração & dosagem , Riboflavina/sangue , S-Adenosil-Homocisteína/sangue , S-Adenosilmetionina/sangue , Sarcosina/análogos & derivados , Sarcosina/sangue , Vitamina B 12/administração & dosagem , Vitamina B 12/sangue , Vitamina B 6/administração & dosagem , Vitamina B 6/sangue , Adulto JovemRESUMO
BACKGROUND: Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system. Riboflavin is involved in myelin formation in nerve cells. Riboflavin is a precursor of flavin adenine D-nucleotide (FAD), which is a coenzyme of methylene tetrahydrofolate reductase (MTHFR), which is an important enzyme for remethylation of homocysteine. Riboflavin supplementation has been shown to affect the serum levels of homocysteine in healthy volunteers. The aim of the present study was to test the effect of riboflavin supplementation on the status and disability of patients with MS and whether this effect could be mediated by serum homocysteine levels. MATERIALS AND METHODS: This was a randomized, double-blind, controlled trial in which 29 MS patients with a mean age of 33 were tested with riboflavin, and the placebo group, with a mean age of 31, received either riboflavin supplementation (10 mg) or the placebo daily for six months. Disability, measured by the Expanded Disability Status Scale (EDSS) scores, erythrocyte glutathione reductase activity coefficient (EGRAC), and serum homocysteine levels were measured before and after the study. RESULTS: The mean ± SD of EDSS score was significantly decreased in both groups over the six months of the study (2.3 ± 0.7 vs. 1.6 ± 0.6 for the riboflavin group and 2.8 ± 1.1 vs. 2.3 ± 1.3 for the placebo groups. The comparison across both groups yielded a non-significant change (P = 0.001 and 0.02, respectively). No significant differences were observed between the two groups in terms of EGRAC, riboflavin deficiency levels by EGRAC category, and serum homocysteine levels before and after the study. CONCLUSION: Riboflavin supplementation (10 mg/day) to patients with MS does not improve disability status. It appears that this effect is not related to serum homocysteine levels.
Assuntos
Homocisteína/sangue , Esclerose Múltipla/sangue , Riboflavina/sangue , Riboflavina/farmacologia , Complexo Vitamínico B/sangue , Complexo Vitamínico B/farmacologia , Adulto , Suplementos Nutricionais , Método Duplo-Cego , Eritrócitos/efeitos dos fármacos , Feminino , Glutationa Redutase/sangue , Glutationa Redutase/efeitos dos fármacos , Humanos , Masculino , Riboflavina/administração & dosagem , Complexo Vitamínico B/administração & dosagemRESUMO
SCOPE: Epidemiological studies on the association between pregnancy outcomes and use of periconceptional folic acid are often based on maternal reported intake. Use of folic acid during pregnancy is associated with a higher socioeconomic status known to have an impact on diet quality. We have studied plasma B vitamin status according to reported use of folic acid supplements during the periconceptional period in Norwegian women. METHODS AND RESULTS: Plasma levels of folate, cobalamin, pyridoxal 5'-phosphate (vitamin B6), riboflavin, and the metabolic markers total homocysteine, methylmalonic acid and 3-hydro-xykynurenine were measured in pregnancy week 18 and related to reported intake of folic acid from 4 weeks prior to conception throughout week 18 in 2911 women from the Norwegian Mother and Child Cohort Study (MoBa) conducted by the Norwegian Institute of Public Health. Being a folic acid user during the periconceptional period was associated with a better socioeconomic status, and a higher intake of several micronutrients, including vitamins, trace-metals, and omega 3 fatty acids. Folic acid users had a significantly better plasma B vitamin status. CONCLUSION: Epidemiological data based on maternal reported intake of folic acid supplements during pregnancy, should take into account the numerous nutritional implications, in addition to higher blood folate levels, of being a folic acid user.
Assuntos
Suplementos Nutricionais , Ácido Fólico/administração & dosagem , Fenômenos Fisiológicos da Nutrição Materna , Gravidez , Complexo Vitamínico B/administração & dosagem , Adulto , Biomarcadores/sangue , Ácidos Graxos Ômega-3/administração & dosagem , Feminino , Ácido Fólico/sangue , Homocisteína/sangue , Humanos , Ácido Metilmalônico/sangue , Micronutrientes/administração & dosagem , Noruega , Estudos Prospectivos , Riboflavina/sangue , Fatores Socioeconômicos , Inquéritos e Questionários , Vitamina B 12/sangue , Vitamina B 6/sangue , Complexo Vitamínico B/sangueRESUMO
BACKGROUND: Linear programming has been used for analyzing children's complementary feeding diets, for optimizing nutrient adequacy of dietary recommendations for a population, and for estimating the economic value of fortified foods. OBJECTIVE: To describe and apply a linear programming tool ("Cost of the Diet") with data from Mozambique to determine what could be cost-effective fortification strategies. METHODS: Based on locally assessed average household dietary needs, seasonal market prices of available food products, and food composition data, the tool estimates the lowest-cost diet that meets almost all nutrient needs. The results were compared with expenditure data from Mozambique to establish the affordability of this diet by quintiles of the population. RESULTS: Three different applications were illustrated: identifying likely "limiting nutrients," comparing cost effectiveness of different fortification interventions at the household level, and assessing economic access to nutritious foods. The analysis identified iron, vitamin B2, and pantothenic acid as "limiting nutrients." Under the Mozambique conditions, vegetable oil was estimated as a more cost-efficient vehicle for vitamin A fortification than sugar; maize flour may also be an effective vehicle to provide other constraining micronutrients. Multiple micronutrient fortification of maize flour could reduce the cost of the "lowest-cost nutritious diet" by 18%, but even this diet can be afforded by only 20% of the Mozambican population. CONCLUSIONS: Within the context of fortification, linear programming can be a useful tool for identifying likely nutrient inadequacies, for comparing fortification options in terms of cost effectiveness, and for illustrating the potential benefit of fortification for improving household access to a nutritious diet.